Hepatitis C News

• New Approach Identifies Infectious Causes of Chronic Meningitis
  Reuters Health Information, April 2018
• ACIP Recommends Heplisav-B Vaccine for Adults Heplisav-B, a yeast-derived hepatitis B vaccine made with a novel adjuvant, is recommended for individuals aged 18 years and older, according to the Advisory Committee on Immunization Practices.
  Medscape Medical News, April 2018
• Quick Portable Test Could Widen Reach of HCV Diagnosis
  Reuters Health Information, April 2018
• ISHLT 2018Hepatitis C-infected Heart and Lung Transplants Safe Organs donated from people infected with hepatitis C can be safely transplanted, and any transmission of the virus can be treated with antiretrovirals, new research shows.
  Medscape Medical News, April 2018
• ILC 2018Hep C Treatments Save Care Costs if Administered Early The early initiation of a pan-genotypic regimen lowers the cost of future care, report health economists who say current policies that base access to treatment on disease stage might be short-sighted.
  Medscape Medical News, April 2018
• Patient Advocacy Groups Take in Millions From Drugmakers. Is There Payback? Kaiser Health News launches 'Pre$cription for Power,' a groundbreaking database to expose Big Pharma’s ties to patient groups.
  Kaiser Health News, April 2018
• ILC 2018Liver Cancer on the Rise in Backdrop of Undiagnosed Hep C The hepatitis C epidemic that started in the 1950s infected many patients who are now developing end-stage liver cancer, and the number of cases is growing, researchers report.
  Medscape Medical News, April 2018
• ISHLT 2018Trailblazing Transplant Research Expanding Organ Options Heart donation after circulatory death and new insights into the suitability of organ donations will be debated at the upcoming heart and lung transplantation scientific sessions.
  Medscape Medical News, April 2018
• Glecaprevir/pibrentasvir Treats Hepatitis C in HIV-coinfected Individuals The direct-acting antiviral (DAA) combination glecaprevir/pibrentasvir is effective for treating hepatitis C virus (HCV) infection in individuals coinfected with HIV-1, according to results from the non-randomized, open-label phase 3 EXPEDITION-2 trial.
  Reuters Health Information, April 2018
• Resection Bests Chemoembolization in Selected Liver Cancer Patients Resection offers survival benefits in carefully selected patients with intermediate-to-advanced hepatocellular carcinoma (HCC), researchers in Korea suggest.
  Reuters Health Information, March 2018
• Alcohol-Related Liver Cancer Diagnosed at Later Stages Liver cancer related to alcohol consumption is assosciated with worse outcomes than other types of liver cancer, primarily owing to later diagnosis.
  Medscape Medical News, March 2018
• Prior Chlamydia Infection and Doubled Risk for Ovarian Cancer Pelvic inflammatory disease, which is often caused by sexually transmitted disease, increases ovarian cancer risk; Chlamydia appears to double the risk.
  Medscape Medical News, March 2018
• Drug Costs Slowing Down, but Still High for Specialty Drugs As in 2016, Humira was among most expensive drugs, but spending on hepatitis C therapies dropped precipitously.
  Medscape Medical News, March 2018
• Antivirals May Prevent Chronic HCV in Recipients of Infected Donor Kidneys Pre- and post-transplant treatment with direct-acting antivirals is safe and may prevent chronic hepatitis C virus (HCV) infection in patients who receive a kidney from an HCV-positive donor, a small study suggests.
  Reuters Health Information, March 2018
• African-Americans Less Likely to Respond to Direct-acting Antivirals for Hep-C African-Americans are less likely than other patients to achieve sustained virological response 12 weeks (SVR12) after completion of direct-acting antiviral treatment for hepatitis C virus (HCV) infection, according to a retrospective study of U.S. military veterans.
  Reuters Health Information, March 2018
• Best Practice Testing Failed to ID Hidden HCV Infections A best practices HCV and HBV testing strategy failed to find hidden HCV infections, a study found. This approach may not work in low-prevalence countries.
  Medscape Medical News, January 2018
• From Retirement to the Front Lines of Hepatitis C Treatment This doctor came out of retirement with the goal of treating every patient at high risk for hepatitis C he encounters. The problem is finding them.
  Kaiser Health News, January 2018
• Treating the New Hep C Generation on Their Turf One Northern California physician is a foot soldier in the fight against a surge of hepatitis C, mainly among young drug users who share infected needles.
  Kaiser Health News, December 2017
• Lab Screening of Kids Entering Foster Care May Have Low Yield Laboratory screening for infectious diseases in children entering foster care yields few results that are clinically meaningful, researchers report.
  Reuters Health Information, November 2017
• ANACOpioid Crisis Inflaming Hep C, HIV in Hard-Hit Communities The opioid epidemic is having an effect on hepatitis C and HIV transmissions, new state-by-state data show, but funding shortcomings are translating into treatment gaps that have some experts worried.
  Medscape Medical News, November 2017